Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Wareham

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Cell Metabolism|October 3, 2006
Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistanceMaura Agostini, Erik Schoenmakers, Catherine Mitchell, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCTSimon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
Disease Markers|May 2, 2017
Functional Analysis of the Coronary Heart Disease Risk Locus on Chromosome 21q22Katherine E Beaney, Andrew J P Smith, Lasse Folkersen, et al.
Diabetes|February 2, 2011
Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistanceN Maneka G De Silva, Rachel M Freathy, Tom M Palmer, et al.
Journal of Epidemiology and Community Health|December 10, 2024
Examining causal relationships between educational attainment and type 2 diabetes using genetic analysis: findings from the EPIC-InterAct study through Mendelian randomisationAlessandra Macciotta, Carlotta Sacerdote, Claudia Giachino, et al.
Diabetes|December 6, 2014
Sixty-five common genetic variants and prediction of type 2 diabetesPhilippa J Talmud, Jackie A Cooper, Richard W Morris, et al.
Oncology Reports|July 5, 2011
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on CancerDaniele Campa, Anika Hüsing, Lucie Dostal, et al.
Mutagenesis|July 14, 2011
Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC)Wei Wei Xun, Paul Brennan, Anne Tjonneland, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 13, 2012
A risk model for lung cancer incidenceClive Hoggart, Paul Brennan, Anne Tjonneland, et al.
Plos One|March 5, 2011
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Anika Hüsing, Angelika Stein, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Cell Metabolism|October 3, 2006
Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistanceMaura Agostini, Erik Schoenmakers, Catherine Mitchell, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCTSimon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
Disease Markers|May 2, 2017
Functional Analysis of the Coronary Heart Disease Risk Locus on Chromosome 21q22Katherine E Beaney, Andrew J P Smith, Lasse Folkersen, et al.
Diabetes|February 2, 2011
Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistanceN Maneka G De Silva, Rachel M Freathy, Tom M Palmer, et al.
Journal of Epidemiology and Community Health|December 10, 2024
Examining causal relationships between educational attainment and type 2 diabetes using genetic analysis: findings from the EPIC-InterAct study through Mendelian randomisationAlessandra Macciotta, Carlotta Sacerdote, Claudia Giachino, et al.
Diabetes|December 6, 2014
Sixty-five common genetic variants and prediction of type 2 diabetesPhilippa J Talmud, Jackie A Cooper, Richard W Morris, et al.
Oncology Reports|July 5, 2011
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on CancerDaniele Campa, Anika Hüsing, Lucie Dostal, et al.
Mutagenesis|July 14, 2011
Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC)Wei Wei Xun, Paul Brennan, Anne Tjonneland, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 13, 2012
A risk model for lung cancer incidenceClive Hoggart, Paul Brennan, Anne Tjonneland, et al.
Plos One|March 5, 2011
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Daniele Campa, Anika Hüsing, Angelika Stein, et al.
Pageof 12